Skip to main content
Clinical Trials/NCT05756738
NCT05756738
Recruiting
Not Applicable

Acceptance and Feasibility of Hepatitis c Screening Strategies in Social Insertion Centers With Alternative Sentences to Prison and Open System

University of La Laguna1 site in 1 country854 target enrollmentMarch 10, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hepatitis C Virus
Sponsor
University of La Laguna
Enrollment
854
Locations
1
Primary Endpoint
Number of participants in a HCV screening strategy
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Hepatitis C virus (HCV) infection is one of the leading causes of chronic liver disease worldwide. It is a progressive disease that without treatment leads to the development of cirrhosis in approximately 10-20% of patients. With this study the investigators intend to evaluate the efficacy defined as the rate of HCV diagnostic tests performed within a decentralized diagnostic strategy by means of home self-testing compared to the one performed in situ in the population served in Social Insertion Centers (CIS) with alternative prison sentences, in order to study the prevalence and characteristics associated with HCV infection in this population, which is known to be at risk for this disease, and to offer them treatment and cure.

Detailed Description

A randomized study will be designed in which all persons attending the Social Insertion Center to serve alternative sentences to prison will be invited to participate on a voluntary basis, with prior informed consent. In order to study the prevalence of these persons compared to persons in open system, the latter will be offered, with prior informed consent, to take the diagnostic test in situ at the CIS premises. All persons will be given a survey with sociodemographic and clinical variables to identify predictor factors. People with alternative sentences to prison will be informed of the study and, according to the randomization code, will be: a) given an envelope with all the necessary material to carry out the test at home and send it to the hospital for processing or, b) be tested on site at the CIS premises by the CIS nurse, who will also send it to the hospital for processing within 30 days by the Central Laboratory of the University Hospital of the Canary Islands.

Registry
clinicaltrials.gov
Start Date
March 10, 2023
End Date
January 10, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of La Laguna
Responsible Party
Principal Investigator
Principal Investigator

Manuel Hernandez-Guerra, MD

Principal Investigator

University of La Laguna

Eligibility Criteria

Inclusion Criteria

  • All persons attending the Social Insertion Center for the first time with alternative sentences to prison and in open system.
  • Signed informed consent.

Exclusion Criteria

  • Refusal of the patient to participate in the study.
  • Minors under 18 years of age and over 79 years of age.

Outcomes

Primary Outcomes

Number of participants in a HCV screening strategy

Time Frame: 1 year

To evaluate the efficacy defined as the rate of diagnostic tests against hepatitis C virus (HCV) performed within a decentralized diagnostic strategy integrated by self-testing at home compared to that performed in situ in the population served in a Social Insertion Center with alternative prison sentences.

Secondary Outcomes

  • Prevalence of HCV(1 year)

Study Sites (1)

Loading locations...

Similar Trials